Transforming the way that drugs are discovered and delivered to patients.
Core business
Insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. They are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high throughput, quantitative biology. Their aim is to eliminate key bottlenecks in traditional drug discovery, so they can help more people sooner and at a much lower cost to the patient and the healthcare industry.
The company uses state-of-the-art technologies from bioengineering enabling it to generate high-throughput, functional genomic data sets and aligning them with patient data via novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics.
About the company
Insitro was established in 2018 by Daphne Koller in South San Francisco, CA. At Insitro, they set out to create a unique culture uniting individuals from diverse backgrounds in a single team, where deeply experienced biologists and drug hunters work hand-in-hand with leading edge technologists and machine learners.
Affiliated Interns
Gelana Khazeeva
Data Science & Machine Learning Intern: Computational Biology
